Clinical Trials on Partial Drug-resistant Epilepsy in United States
Total 277 results
-
Pavel KleinH. Lundbeck A/SUnknown
-
PfizerCompletedEpilepsy, PartialUnited States, Germany
-
Emory UniversityCenters for Disease Control and PreventionRecruitingMulti-drug Resistant OrganismUnited States
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
Marinus PharmaceuticalsCompletedEpilepsy, Complex PartialUnited States
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS); MedtronicActive, not recruitingEpilepsyUnited States
-
Mid-Atlantic Epilepsy and Sleep Center, LLCEisai Inc.TerminatedEpilepsyUnited States
-
Wayne State UniversityNational Institutes of Health (NIH)RecruitingFocal EpilepsyUnited States
-
National Institute of Neurological Disorders and...Recruiting
-
H. Lundbeck A/STerminatedFocal EpilepsyUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Bial - Portela C S.A.CompletedPartial Epilepsy in Children and AdolescentsUnited Kingdom, Spain, Serbia, Italy, Austria, Bosnia and Herzegovina, Croatia, Czechia, France, Germany, Hungary, Malaysia, Moldova, Republic of, Philippines, Poland, Portugal, Romania, Russian Federation, Slovakia, Taiwan, Ukr...
-
Supernus Pharmaceuticals, Inc.CompletedSafety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyPartial EpilepsyUnited States, Poland, Bulgaria, Romania, Canada, Russian Federation, Mexico, Croatia
-
Cyberonics, Inc.TerminatedEpilepsy | Partial EpilepsyCanada, Spain, Belgium, France, Germany, Italy, Netherlands, Norway, Sweden, United Kingdom
-
National Institute of Mental Health (NIMH)Completed
-
UCB PharmaCompletedPartial EpilepsiesUnited States, Poland, United Kingdom, Switzerland, Hungary, Germany, Sweden, Lithuania
-
Marinus PharmaceuticalsCompletedPartial Epilepsy | Catamenial EpilepsyUnited States
-
Eisai Inc.CompletedEpilepsyAustralia, France, Poland, Germany, Spain, India, Serbia, Greece, Korea, Republic of, Russian Federation, Taiwan, Hungary, Italy, Sweden, Denmark, Slovakia, United Kingdom, South Africa
-
UCB S.A. - Pharma SectorCompletedEpilepsy, PartialUnited States
-
National Institute of Allergy and Infectious Diseases...TerminatedTuberculosis, Pulmonary | Mycobacterium Tuberculous | Antitubercular Agents | Tuberculosis, Mulutidrug-Resistant | Extensively Drug-Resistant | Extensibely Drug-Resistant TuberculosisUnited States, Mali
-
King's College LondonNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
The Methodist Hospital Research InstituteM.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... and other collaboratorsRecruitingAntibiotic Resistant Infection | Clostridium Difficile | Antimicrobial Drug Resistance | Carbapenem-Resistant Enterobacteriaceae Infection | Vancomycin Resistant Enterococci Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection | Extended Spectrum Beta-Lactamase...United States
-
LivaNovaCompletedEpilepsies, Partial | Epilepsy, Tonic-ClonicUnited States, Belgium
-
SK Life Science, Inc.RecruitingPartial EpilepsyKorea, Republic of, United States
-
Janssen Research & Development, LLCCompletedPulmonary Multi-drug Resistant TuberculosisUnited States
-
InSightecFood and Drug Administration (FDA)Recruiting
-
Massachusetts General HospitalBoston University; National Institute of Neurological Disorders and Stroke...RecruitingEpilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of ChildhoodUnited States
-
Medstar Health Research InstituteUnknownIncreased Drug ResistanceUnited States
-
National Institute of Neurological Disorders and...Completed
-
Emory UniversityTerminated
-
The University of Texas Health Science Center,...National Institute of Neurological Disorders and Stroke (NINDS)Recruiting
-
SunovionCompletedEpilepsy With Simple or Complex Partial Onset SeizuresUnited States, Canada
-
University of Southern CaliforniaRecruiting
-
UCB BIOSCIENCES, Inc.CompletedPartial EpilepsiesUnited States
-
National Institute of Neurological Disorders and...Completed
-
BiogenCompletedEpilepsy, Focal Seizures, Partial SeizuresUnited States
-
George Washington UniversityCompletedMesial Temporal Lobe EpilepsyUnited States
-
UCB Pharma SACompletedEpilepsy, PartialCanada, United States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
National Institute of Mental Health (NIMH)Completed
-
UCB PharmaCompletedPartial EpilepsiesUnited States, Austria, Bulgaria, Czechia, Denmark, Finland, France, Greece, Italy, Mexico, Romania, Russian Federation, Spain, Switzerland, Turkey
-
National Institute of Neurological Disorders and...TerminatedDepression | Epilepsy | Seizures | Anxiety Disorder | Partial EpilepsyUnited States
-
Centers for Disease Control and PreventionColumbia University; New York City Department of Health and Mental HygieneCompletedTuberculosis | Adherence, Medication | Drug-resistant Tuberculosis | Adherence, PatientUnited States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Eisai Inc.CompletedEpilepsy, Complex PartialUnited States, Estonia, Ukraine, Hungary, Lithuania
-
Bial - Portela C S.A.SunovionCompletedPartial EpilepsyUnited States, Argentina, Germany, France, Belgium, Canada, Italy, Poland, Greece, Brazil, Cyprus
-
SunovionCompletedEpilepsyUnited States, Bulgaria, Czech Republic, Serbia, Ukraine
-
PfizerCompletedEpilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial | Epilepsy, Complex PartialUnited States
-
National Institute of Neurological Disorders and...CompletedEpilepsy | Temporal LobeUnited States
-
Global Alliance for TB Drug DevelopmentCompletedMulti-drug Resistant TuberculosisUnited States